
CAS: 1030769-75-5
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
![]() | SRI 37892 REF: TM-T9662CAS: 1030769-75-5 | 98.92% | 378,00 €~3.353,00 € | Mar 15 Abr 25 |
![]() | SRI 37892 REF: 54-BUP07634CAS: 1030769-75-5 | 98.91% | 2.509,00 €~5.611,00 € | Mar 15 Abr 25 |
![]() | 4-(1H-Benzo[D]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide REF: 3D-FRB76975CAS: 1030769-75-5 | Min. 95% | A consultar | Mar 27 May 25 |

SRI 37892
CAS:1030769-75-5
SRI 37892 is a Fzd7 inhibitor with potent activities against Wnt/β-catenin signaling and cancer cell …
Fórmula:
C26H19N5O2S
Pureza:
98.92%
Forma y color:
Liquid
Peso molecular:
465.53
Ref: TM-T9662
1mg | 378,00 € | ||
5mg | 922,00 € | ||
10mg | 1.225,00 € | ||
25mg | 1.853,00 € | ||
50mg | 2.490,00 € | ||
100mg | 3.353,00 € | ||
1mL*10mM (DMSO) | 1.074,00 € |
Entrega estimada en Estados Unidos, el Martes 15 de Abril de 2025

Ref: 54-BUP07634
25mg | 2.509,00 € | ||
50mg | 3.369,00 € | ||
100mg | 4.539,00 € | ||
200mg | 5.611,00 € |
Entrega estimada en Estados Unidos, el Martes 15 de Abril de 2025

4-(1H-Benzo[D]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide
Producto controladoCAS:1030769-75-5
Please enquire for more information about 4-(1H-Benzo[D]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide including the price, delivery time and more detailed …
Fórmula:
C26H19N5O2S
Pureza:
Min. 95%
Peso molecular:
465.5 g/mol
Ref: 3D-FRB76975
25mg | 987,00 € | ||
50mg | 1.295,00 € |
Entrega estimada en Estados Unidos, el Martes 27 de Mayo de 2025